Back to search

A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.

Data up to Jan 2025

Published2013
Citations152
References0
Clinical Trials (1)

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...